Is dementia a vaccine-preventable condition?

⏱ 2 min read, 60 min video

When you think about vaccines, you probably think about preventing infections — but could they also help protect your memory and thinking skills? In a recent webinar, immunologist Dr. Dawn Bowdish explored the question: Is dementia vaccine-preventable? Her insights shed light on how infections, inflammation, and immunity intersect with brain health.

 

 

View Transcript

Highlights include:

  • 00:00 Introduction: Vaccines and dementia prevention
  • 07:06 What can super-centenarians tell us? 
  • 10:14 Can inflammatory events accelerate dementia? 
  • 15:03 How might vaccination reduce dementia risk?
  • 30:14 When to vaccinate and how long it lasts 
  • 33:53 Which vaccines to prioritize at +65 to reduce your dementia risk?
  • 37:52 How old were the people in these studies? 
  • 40:04 Does it matter which shingles vaccine was received and are boosters required?
  • 42:04 How strong is the evidence overall for vaccines and dementia risk reduction? 
  • 45:33 Which dementias do vaccines show protection for? 
  • 48:02 Is the benefit from preventing infections or reducing inflammation?
  • 49:39 Other inflammatory conditions and dementia risk 
  • 51:49 How to address vaccine hesitancy

The surprising link between vaccines and dementia risk

As we age, protecting our cognitive health becomes a top priority. Recent research has shown that up to 45% of dementias could be delayed or prevented by addressing modifiable risk factors. Emerging research suggests that staying up to date on certain vaccines may do more than keep you healthy; it might help reduce your risk of dementia.

Key insights from the webinar

  • Infections and inflammation: Severe infections —  especially respiratory illnesses like pneumonia and influenza — can accelerate cognitive decline. 
  • Shingles vaccine benefits: Large studies in the UK and Australia have shown that shingles vaccination is linked to a 20% lower risk of dementia. This finding has been replicated in multiple populations.
  • Other vaccines may help: Influenza, pneumonia, and possibly RSV vaccines could also play a role in protecting brain health.
  • How it works: Vaccines may prevent infections that trigger harmful inflammation in the brain. Some evidence suggests vaccine adjuvants might even “tune” the immune system for broader benefits.
  • What’s still uncertain: Researchers are still studying the best timing for vaccination, how long the protective effects lasts, and why benefits may be stronger in women.

What you can do

While research continues, one practical takeaway is clear: staying current with recommended adult vaccines, especially shingles and flu, support both physical and cognitive health. Talk to your healthcare provider about which vaccines are right for you.

Your health choices today could help protect your brain for years to come. Vaccines aren’t just about preventing illness; they may be an important part of lifelong brain health.

Tell us what you think

Give us your feedback on this content by answering a few questions. Your participation will help us improve this resource. Take the survey.


Get the latest content first. Sign up for free weekly email alerts.
Subscribe
Author Details
Author Details

References

  1. Priya T, Kalavathi P, Surya Prasath VB, Sivanesan R. Brain tissue volume estimation to detect Alzheimer’s disease in magnetic resonance images. Soft Comput. 2021;25(15):10007-10017. doi:10.1007/s00500-021-05621-8
  2. Holstege H, Pfeiffer W, Sie D, et al. Somatic mutations found in the healthy blood compartment of a 115-yr-old woman demonstrate oligoclonal hematopoiesis. Genome Res. 2014;24(5):733-742. doi:10.1101/gr.162131.113
  3. Santos-Pujol E, Noguera-Castells A, Casado-Pelaez M, et al. The multiomics blueprint of the individual with the most extreme lifespan. Cell Rep Med. 2025;6(10):102368. doi:10.1016/j.xcrm.2025.102368
  4. Holmes C, Cunningham C, Zotova E, et al. Systemic inflammation and disease progression in Alzheimer disease. Neurology. 2009;73(10):768-774. doi:10.1212/WNL.0b013e3181b6bb95
  5. Orihuela C, McElhaney J, Bowdish DME. Consequences of pneumonia in older adults. In: Gu D, Dupre M, eds. Encyclopedia of Gerontology and Population Aging. Cham, Switzerland: Springer; 2019. doi:10.1007/978-3-319-69892-2_550-1
  6. Levine KS, Leonard HL, Blauwendraat C, et al. Virus exposure and neurodegenerative disease risk across national biobanks. Neuron. 2023;111(7):1086-1093.e2. doi:10.1016/j.neuron.2022.12.029
  7. Untersteiner H, Wurm R, Reichardt B, et al. Heightened prevalence of common hospital-treated infections preceding dementia diagnosis with accelerated dementia onset after influenza. J Prev Alzheimers Dis. 2024;11(5):1445-1454. doi:10.14283/jpad.2024.92
  8. Eyting M, Xie M, Michalik F, et al. A natural experiment on the effect of herpes zoster vaccination on dementia. Nature. 2025;641:438-446. doi:10.1038/s41586-025-08800-x
  9. Taquet M, Dercon Q, Todd JA, et al. The recombinant shingles vaccine is associated with lower risk of dementia. Nat Med. 2024;30:2777-2781. doi:10.1038/s41591-024-03201-5
  10. Shah S, Dahal K, Thapa S, et al. Herpes zoster vaccination and the risk of dementia: a systematic review and meta-analysis. Brain Behav. 2024;14(2):e3415. doi:10.1002/brb3.3415
  11. Harris K, Ling Y, Bukhbinder AS, et al. The impact of routine vaccinations on Alzheimer's disease risk in persons 65 years and older: a claims-based cohort study using propensity score matching. J Alzheimers Dis. 2023;95(2):703-718. doi:10.3233/JAD-221231
  12. Bukhbinder A, Ling Y, Hasan O, et al. Risk of Alzheimer’s disease following influenza vaccination: a claims-based cohort study using propensity score matching. J Alzheimers Dis. 2022;88(3):1061-1074. doi:10.3233/JAD-220361
  13. Polisky V, Littmann M, Triastcyn A, et al. Varicella-zoster virus reactivation and the risk of dementia. Nat Med. 2025;31:4172-4179. doi:10.1038/s41591-025-03972-5
  14. Pomirchy M, Bommer C, Pradella F, Michalik F, Peters R, Geldsetzer P. Herpes zoster vaccination and dementia occurrence. JAMA. 2025;333(23):2083-2092. doi:10.1001/jama.2025.5013
  15. Lophatananon A, Carr M, Mcmillan B, et al. The association of herpes zoster and influenza vaccinations with the risk of developing dementia: a population-based cohort study within the UK Clinical Practice Research Datalink. BMC Public Health. 2023;23(1):1903. doi:10.1186/s12889-023-16768-4
  16. Féart C, Helmer C, Fleury H, et al. Association between IgM anti-herpes simplex virus and plasma amyloid-beta levels. PLoS One. 2011;6(12):e29480. doi:10.1371/journal.pone.0029480
  17. Taquet M, Todd JA, Harrison PJ. Lower risk of dementia with AS01-adjuvanted vaccination against shingles and respiratory syncytial virus infections. npj Vaccines. 2025;10:130. doi:10.1038/s41541-025-01172-3
  18. Xie M, Eyting M, Bommer C, Ahmed H, Geldsetzer P. The effect of shingles vaccination at different stages of the dementia disease course. Cell. 2025;188(25):7049-7064.e20. doi:10.1016/j.cell.2025.11.007

AI Disclosure

The image featured in this video post was created using AI tools and refined by our design team.

DISCLAIMER: These summaries are provided for informational purposes only. They are not a substitute for advice from your own health care professional. The summaries may be reproduced for not-for-profit educational purposes only. Any other uses must be approved by the McMaster Optimal Aging Portal (info@mcmasteroptimalaging.org).

Many of our Blog Posts were written before the COVID-19 pandemic and thus do not necessarily reflect the latest public health recommendations. While the content of new and old blogs identify activities that support optimal aging, it is important to defer to the most current public health recommendations. Some of the activities suggested within these blogs may need to be modified or avoided altogether to comply with changing public health recommendations. To view the latest updates from the Public Health Agency of Canada, please visit their website.